CAS 19992-80-4

19992-80-4 82CYO8A460 Butixirate [USAN:INN] Xenbucin trans-4-phenylcyclohexylamine salt (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, (+-)-, compound with trans-4-phenylcyclohexanamine (1:1) 4-Biphenylacetic acid, alpha-ethyl-, compd. with 4-phenylcyclohexylamine (1:1), trans- Butixirate M.G. 5771 Butixirato [INN-Spanish] Butixiratum [INN-Latin] EINECS 243-454-7 trans-alpha-Ethyl-4-biphenylacetic acid compd. with 4-phenylcyclohexylamine (1:1) (+-)-alpha-Ethyl-4-biphenylacetic acid, compound with trans-4-phenylcyclohexylamine (1:1) Flectar MG 5771 trans-4-Phenylcyclohexylamin 2-(4-biphenylyl)butyrat Butixirato Butixiratum UNII-82CYO8A460

纯度 97%+现货药物标准品
CAS 号19992-80-4
分子式C16H16O2 C12H17N
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

19992-80-4 82CYO8A460 Butixirate [USAN:INN] Xenbucin trans-4-phenylcyclohexylamine salt (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, (+-)-, compound with trans-4-phenylcyclohexanamine (1:1) 4-Biphenylacetic acid, alpha-ethyl-, compd. with 4-phenylcyclohexylamine (1:1), trans- Butixirate M.G. 5771 Butixirato [INN-Spanish] Butixiratum [INN-Latin] EINECS 243-454-7 trans-alpha-Ethyl-4-biphenylacetic acid compd. with 4-phenylcyclohexylamine (1:1) (+-)-alpha-Ethyl-4-biphenylacetic acid, compound with trans-4-phenylcyclohexylamine (1:1) Flectar MG 5771 trans-4-Phenylcyclohexylamin 2-(4-biphenylyl)butyrat Butixirato Butixiratum UNII-82CYO8A460 CAS 19992-80-4 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（19992-80-4 82CYO8A460 Butixirate [USAN:INN] Xenbucin trans-4-phenylcyclohexylamine salt (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, (+-)-, compound with trans-4-phenylcyclohexanamine (1:1) 4-Biphenylacetic acid, alpha-ethyl-, compd. with 4-phenylcyclohexylamine (1:1), trans- Butixirate M.G. 5771 Butixirato [INN-Spanish] Butixiratum [INN-Latin] EINECS 243-454-7 trans-alpha-Ethyl-4-biphenylacetic acid compd. with 4-phenylcyclohexylamine (1:1) (+-)-alpha-Ethyl-4-biphenylacetic acid, compound with trans-4-phenylcyclohexylamine (1:1) Flectar MG 5771 trans-4-Phenylcyclohexylamin 2-(4-biphenylyl)butyrat Butixirato Butixiratum UNII-82CYO8A460）为药物标准品，CAS 登记号 19992-80-4，分子式 C16H16O2 C12H17N。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

的产生途径与其化学式中甾体骨架，酰胺类，含羟基，含醚键密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 （19992-80-4 82CYO8A460 Butixirate USAN:INN Xenbucin trans-4-phenylcyclohexylamine salt (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, (+-)-, compound with trans-4-phenylcyclohexanamine (1:1) 4-Biphenylacetic acid, alpha-ethyl-, compd. with 4-phenylcyclohexylamine (1:1), trans- Butixirate M.G. 5771 Butixirato INN-Spanish Butixiratum INN-Latin EINECS 243-454-7 trans-alpha-Ethyl-4-biphenylacetic acid compd. with 4-phenylcyclohexyla

应用场景：（19992-80-4 82CYO8A460 Butixirate USAN:INN Xenbucin trans-4-phenylcyclohexylamine salt (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, (+-)-, compound with trans-4-phenylcyclohexanamine (1:1) 4-Biphenylacetic acid, alpha-ethyl-, compd. with 4-phenylcyclohexylamine (1:1), trans- Butixirate M.G. 5771 B

理化性质 Physical & Chemical Properties

中文名称
分子式C16H16O2 C12H17N
分子量415.58 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件室温保存，避光
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）13.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1962年
含氮原子数1

相关专利 Related Patents

  1. Jørgensen K, Björnsson E, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3596553 A1, 2022-08-07.
  2. 发明人钱学锋，沈红梅，韩伟. "Method for the Synthesis of 19992-80-4 82CYO8A460 Butixirate [USAN:INN] Xenbucin trans-4-phenylcyclohexylamine salt (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, (+-)-, compound with trans-4-phenylcyclohexanamine (1:1) 4-Biphenylacetic acid, alpha-ethyl-, compd. with 4-phenylcyclohexylamine (1:1), trans- Butixirate M.G. 5771 Butixirato [INN-Spanish] Butixiratum [INN-Latin] EINECS 243-454-7 trans-alpha-Ethyl-4-biphenylacetic acid compd. with 4-phenylcyclohexylamine (1:1) (+-)-alpha-Ethyl-4-biphenylacetic acid, compound with trans-4-phenylcyclohexylamine (1:1) Flectar MG 5771 trans-4-Phenylcyclohexylamin 2-(4-biphenylyl)butyrat Butixirato Butixiratum UNII-82CYO8A460" [P]. 中国发明专利, 专利号 CN 108079756 B, 授权公告日 2022-07-18.

参考文献 Literature

  1. Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2013, 1326, (2), 7507-7510.
  2. Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2010, 599, (7), 6766-6787.
  3. Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 19992-80-4 82CYO8A460 Butixirate [USAN:INN] Xenbucin trans-4-phenylcyclohexylamine salt (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, (+-)-, compound with trans-4-phenylcyclohexanamine (1:1) 4-Biphenylacetic acid, alpha-ethyl-, compd. with 4-phenylcyclohexylamine (1:1), trans- Butixirate M.G. 5771 Butixirato [INN-Spanish] Butixiratum [INN-Latin] EINECS 243-454-7 trans-alpha-Ethyl-4-biphenylacetic acid compd. with 4-phenylcyclohexylamine (1:1) (+-)-alpha-Ethyl-4-biphenylacetic acid, compound with trans-4-phenylcyclohexylamine (1:1) Flectar MG 5771 trans-4-Phenylcyclohexylamin 2-(4-biphenylyl)butyrat Butixirato Butixiratum UNII-82CYO8A460 Using HRMS and NMR". Talanta, 2025, 1241, 5751-5772.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...